Received Apr 16, 2026
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| HEPA | HEP A (HAVRIX) | GLAXOSMITHKLINE BIOLOGICALS | UNK | HR4RB | — |
adultpatient received an expired dose ofHavrix on April 9th 2026. Dose expiredon December 18th 2025.; This non-serious case was reported by a other health professional via call center representative and described the occurrence of expired vaccine used in a adult female patient who received HAV (Havrix) (batch number HR4RB, expiry date 18-DEC-2025) for prophylaxis. On 09-APR-2026, the patient received Havrix. On 09-APR-2026, an unknown time after receiving Havrix, the patient experienced expired vaccine used (Verbatim: adultpatient received an expired dose ofHavrix on April 9th 2026. Dose expiredon December 18th 2025.). The outcome of the expired vaccine used was not applicable. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional Information: GSK receipt date 09-APR-2026 The reporter consented to follow up.